Mitochondrial encephalomyopathies are important causes of mental retardation. The investigators are focusing on disorders associated with mitochondrial DNA (mtDNA) point mutations, especially mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). In his project, Dr. D. C. De Vivo, P.I., will continue to characterize the natural history of MELAS, correlating cognitive and behavioral deficits in probands and oligosymptomatic relatives with cerebral energy metabolism assessed by MRI and MRSI. He will also continue a clinical trial with dichloroacetate (DCA) to be completed in 2006. This is a placebo-controlled, randomized, blinded three-year study of a large cohort of MELAS patients. In this unique patient population, Dr. De Vivo will study early biomarkers of brain dysfunction using brain imaging techniques (PET, fMRI). In his project,: Dr. E. A. Schon, P.I., will concentrate on pharmacological approaches to mtDNA-related disorders aimed at """"""""downshifting"""""""" the percentage of mutant mtDNAs. His findings that ketone bodies act as selection agents for wild-type function in cultured cybrid cells heteroplasmic for the T8993G NARP mutation will be extended to cybrid cell lines harboring other mutations, including the A3243G MELAS mutation. To approximate clinical conditions, he will ask whether the downshifting effect of ketone bodies persists in the presence of other substrates, and whether it occurs in terminally differentiated cells, such as myotubes. In his project, Dr. M. Davidson, P.I., will generate an in vitro model of the blood-brain barrier (BBB) to confirm preliminary neuropathological data (Project by Bonilla) suggesting a breakdown of BBB function in MELAS. The model is based on co-cultures of human astrocytes and endothelial cells, both normal and homoplasmic for the A3243G MELAS mutation. In his project, Dr. E. Bonilla, P.I., will extend preliminary studies on two brain structures: the choroids plexus and the ependyma, involved in the BBB and in cerebrospinal fluid (CSF) homeostasis. He will determine the distribution of the lactate and water transporters and of tight junction proteins in the BBB of normal and MELAS brains using immunohistochemistry and immunoblotting. To correlate neuropsychological findings in MELAS patients (Project by Devine) with neuropathology, he will conduct immunohistological and molecular studies of respiratory chain components and of calcium-binding proteins in the hippocampus of patients with MELAS. The Core Unit (Dr. S. DiMauro, Director; Dr. E. A. Schon, Co-Director) will provide direction, administration, external consultation, and shared equipment/technical service to the program as a whole.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
5P01HD032062-14
Application #
7343193
Study Section
Special Emphasis Panel (ZHD1-MRG-C (DS))
Program Officer
Vitkovic, Ljubisa
Project Start
1996-12-01
Project End
2009-11-30
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
14
Fiscal Year
2008
Total Cost
$1,569,268
Indirect Cost
Name
Columbia University (N.Y.)
Department
Neurology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Barca, Emanuele; Ganetzky, Rebecca D; Potluri, Prasanth et al. (2018) USMG5 Ashkenazi Jewish founder mutation impairs mitochondrial complex V dimerization and ATP synthesis. Hum Mol Genet 27:3305-3312
Pera, Marta; Larrea, Delfina; Guardia-Laguarta, Cristina et al. (2017) Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J 36:3356-3371
Fryer, Robert H; Bain, Jennifer M; De Vivo, Darryl C (2016) Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options. Pediatr Neurol 56:59-61
Varma, Hemant; Faust, Phyllis L; Iglesias, Alejandro D et al. (2016) Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. Eur J Med Genet 59:540-5
Piekutowska-Abramczuk, Dorota; Kocy?a-Karczmarewicz, Beata; Ma?kowska, Maja et al. (2016) No Evidence for Association of SCO2 Heterozygosity with High-Grade Myopia or Other Diseases with Possible Mitochondrial Dysfunction. JIMD Rep 27:63-8
Cloonan, Suzanne M; Glass, Kimberly; Laucho-Contreras, Maria E et al. (2016) Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med 22:163-74
Engelstad, Kristin; Sklerov, Miriam; Kriger, Joshua et al. (2016) Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Hum Reprod 31:1058-65
Ripolone, Michela; Ronchi, Dario; Violano, Raffaella et al. (2015) Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy. JAMA Neurol 72:666-75
Levy, Rebecca J; Ríos, Purificación Gutierrez; Akman, Hasan O et al. (2014) Long survival in patients with leigh syndrome and the m.10191T>C mutation in MT-ND3 : a case report and review of the literature. J Child Neurol 29:NP105-10
Garone, Caterina; Garcia-Diaz, Beatriz; Emmanuele, Valentina et al. (2014) Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency. EMBO Mol Med 6:1016-27

Showing the most recent 10 out of 241 publications